Denise Uyar

A Biomarker-enriched, Randomized Phase II Trial of Adavosertib (AZD1775) Plus Paclitaxel and Carboplatin for Women with Platinum-sensitive <i>TP53</i> -mutant Ovarian Cancer

Amit M. Oza, Maria Del Pilar Estevez-Diz, Eva‐Maria Grischke et al. · Clinical Cancer Research · 2020 · 118 citations · Full text

Treatment patterns by decade of life in elderly women (≥70 years of age) with ovarian cancer

Denise Uyar, Heidi E. Frasure, Maurie Markman et al. · Gynecologic Oncology · 2005 · 113 citations

Geriatric Oncology, Aging, Ovarian Aging +13

Genomics of Cervical Cancer and the Role of Human Papillomavirus Pathobiology

Denise Uyar, Janet S. Rader · Clinical Chemistry · 2013 · 66 citations · Full text

Genetics, Human Papillomavirus Pathobiology, Pathology +27

Phase II study of single-agent cabozantinib in patients with recurrent clear cell ovarian, primary peritoneal or fallopian tube cancer (NRG-GY001)

Panagiotis A. Konstantinopoulos, William E. Brady, John Farley et al. · Gynecologic Oncology · 2018 · 63 citations

Gastrointestinal Oncology, Medicine, Metronomic Therapy +8

Hypermethylation of miR-203 in endometrial carcinomas

Yi-Wen Huang, Chieh Kuo, Jo-Hsin Chen et al. · Gynecologic Oncology · 2014 · 53 citations · Full text

Medicine, Pathology, Small Rna +3